Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st New Schizophrenia Drug in Decades
FDA Approves Potentially Groundbreaking Schizophrenia Drug
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” the Food and Drug Administration said.
FDA Approves the First New Type of Schizophrenia Drug in Decades
Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle movement, and sedation — that can cause patients to discontinue treatment.
C&EN
21h
FDA approves Cobenfy, a first-in-class schizophrenia drug
The
FDA
says people with known liver impairment or ... “There’s just been nothing new in this field because the heterogeneity of
schizophrenia
has made identification of improved
drug
targets ...
20h
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
Stadiums to serve as shelters
Promotes watch collection
Targeted Black residents?
Pleads not guilty
World's oldest cheese found
Killer gets life sentence
50/50 ball ownership suit
Producing doc on Diddy
Urgent safety alert for 737s
Chinese submarine sank
Ending password-sharing
NC board removes 747K
Boxes to distribute Narcan
Fake Biden robocalls fine
Heads to US-Mexico border
NIH finds misconduct
WI duplicate ballot flap
On Secret Service failures
More executives leave
ISR targets Hezbollah HQ
US charges three Iranians
Farmers want flu vaccine
Fed inflation gauge cools
Related topics
Bristol-Myers Squibb
Cobenfy
Feedback